DTE

34.36

-0.06%↓

IBE

15.175

+1.37%↑

EOAN

14.07

+0.54%↑

RWE

33.89

+2.45%↑

VER1

66.2

+1.3%↑

DTE

34.36

-0.06%↓

IBE

15.175

+1.37%↑

EOAN

14.07

+0.54%↑

RWE

33.89

+2.45%↑

VER1

66.2

+1.3%↑

DTE

34.36

-0.06%↓

IBE

15.175

+1.37%↑

EOAN

14.07

+0.54%↑

RWE

33.89

+2.45%↑

VER1

66.2

+1.3%↑

DTE

34.36

-0.06%↓

IBE

15.175

+1.37%↑

EOAN

14.07

+0.54%↑

RWE

33.89

+2.45%↑

VER1

66.2

+1.3%↑

DTE

34.36

-0.06%↓

IBE

15.175

+1.37%↑

EOAN

14.07

+0.54%↑

RWE

33.89

+2.45%↑

VER1

66.2

+1.3%↑

Kodu・Aktsiate loetelu・STRATEC Biomedical AG

STRATEC Biomedical AG

Avatud

23.8 -3.64

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

23.15

Max

24.95

Põhinäitajad
By Trading Economics
Sissetulek	-2.9M 549K
Müük	-11M 57M
P/E Sektori keskmine	29.695 28.692
Dividenditootlus	2.16
Kasumimarginaal	0.959
Töötajad	1,462
EBITDA	-3.3M 7.1M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+64.27% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.16% 3.67%
Järgmine tulemuste avaldamine	29. apr 2025

Turustatistika
By TradingEconomics
Turukapital	296M
Eelmine avamishind	27.44
Eelmine sulgemishind	23.8

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

24 / 25.5 Toetus ja vastupanu

STRATEC Biomedical AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. apr 2025, 23:15 UTC

Suurimad hinnamuutused turgudel

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

1. apr 2025, 23:46 UTC

Market Talk

Market Grapples With Valuing Goodman's Data Centers -- Market Talk

1. apr 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. apr 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

1. apr 2025, 23:44 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

1. apr 2025, 23:43 UTC

Market Talk

Gold Steady, Underpinned by Signs of Chinese Buying Activity -- Market Talk

1. apr 2025, 23:11 UTC

Peamised uudised

Risk Off Trade Is Getting Crowded. It's More Worry Than Panic. -- Barrons.com

1. apr 2025, 23:02 UTC

Market Talk

New Zealand May Be Measuring Stick for Trade-War Fallout -- Market Talk

1. apr 2025, 22:31 UTC

Peamised uudised

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1. apr 2025, 22:26 UTC

Market Talk

RBA's Focus on What It Doesn't Know Boosts May Cut Odds -- Market Talk

1. apr 2025, 21:47 UTC

Peamised uudised

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1. apr 2025, 21:32 UTC

Peamised uudised

Hooters' Bankruptcy Is the Latest Sign of Trouble for Restaurants -- Barrons.com

1. apr 2025, 21:06 UTC

Market Talk

Mexican Remittances See Slow Start to the Year -- Market Talk

1. apr 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

1. apr 2025, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

1. apr 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. apr 2025, 20:47 UTC

Peamised uudised

Boeing Stock Drops. Why Lower 737 MAX Production Report Wasn't Quite Right. -- Barrons.com

1. apr 2025, 20:47 UTC

Peamised uudised

BYD Will Beat Tesla Two Ways This Quarter -- Barrons.com

1. apr 2025, 20:20 UTC

Peamised uudised

Trump's 'Liberation Day' Tariffs Loom; Treasury Yields Fall -- WSJ

1. apr 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Eaton Completes Acquisition Of Fibrebond >ETN

1. apr 2025, 20:11 UTC

Market Talk

Altria Stock Seen Overvalued Amid Steep Volume Losses -- Market Talk

1. apr 2025, 20:07 UTC

Omandamised, ülevõtmised, äriostud

Johnson & Johnson Intends to Complete Its Acquisition of Intra-Cellular Therapies on or Around April 2 >JNJ

1. apr 2025, 20:00 UTC

Peamised uudised

Americans Are Worried About Tariffs. Consumer Stocks Could Take a Hit. -- Barrons.com

1. apr 2025, 19:46 UTC

Peamised uudised

Visa, American Express Bidding to Win Apple Credit-Card Network, Sources Say -- WSJ

1. apr 2025, 19:43 UTC

Market Talk

Oil Rally Loses Momentum Ahead of U.S. Tariff Plans -- Market Talk

1. apr 2025, 19:17 UTC

Peamised uudised

Meta's Head of AI Research to Resign Amid Computing Push -- Update

1. apr 2025, 19:13 UTC

Market Talk

U.S. Natural Gas Futures Give Back Gains -- Market Talk

1. apr 2025, 19:03 UTC

Market Talk

Don't Rush Into Trade Talks With U.S., Canadian Experts Advise Lawmakers -- Market Talk

1. apr 2025, 19:00 UTC

Market Talk

Gold Slips Ahead of Tariff Day -- Market Talk

1. apr 2025, 18:54 UTC

Market Talk

Mexican Manufacturing PMIs Reflect Tariff Threats -- Market Talk

Võrdlus sarnastega

Hinnamuutus

STRATEC Biomedical AG Prognoos

Hinnasiht

By TipRanks

64.27% tõus

12 kuu keskmine prognoos

Keskmine 40 EUR 64.27%

Kõrge 41 EUR

Madal 39 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi STRATEC Biomedical AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi STRATEC Biomedical AG aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

24 / 25.5Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.